Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’
Adam Fein, PhD, Pembroke Consulting
Advertisement
Articles by Adam Fein, PhD, Pembroke Consulting
Advertisement
Latest Updated Articles
- The Evolving Retail Pharmacy Channel: Implications for Manufacturers
Published: November 7th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
2
LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control
3
Trump Threatens 10% Tariff Hike on Canadian Imports After Controversial Reagan Ad Airs During World Series
4
